IDX:MEDC Statistics
Total Valuation
IDX:MEDC has a market cap or net worth of IDR 29.74 trillion. The enterprise value is 87.80 trillion.
| Market Cap | 29.74T |
| Enterprise Value | 87.80T |
Important Dates
The next estimated earnings date is Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:MEDC has 24.68 billion shares outstanding. The number of shares has decreased by -1.44% in one year.
| Current Share Class | 24.68B |
| Shares Outstanding | 24.68B |
| Shares Change (YoY) | -1.44% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 3.98% |
| Float | 6.15B |
Valuation Ratios
The trailing PE ratio is 11.63 and the forward PE ratio is 3.71.
| PE Ratio | 11.63 |
| Forward PE | 3.71 |
| PS Ratio | 0.72 |
| PB Ratio | 0.73 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | 3.94 |
| P/OCF Ratio | 1.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.58, with an EV/FCF ratio of 11.62.
| EV / Earnings | 34.37 |
| EV / Sales | 2.11 |
| EV / EBITDA | 3.58 |
| EV / EBIT | 6.44 |
| EV / FCF | 11.62 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 1.56.
| Current Ratio | 1.12 |
| Quick Ratio | 0.92 |
| Debt / Equity | 1.56 |
| Debt / EBITDA | 2.90 |
| Debt / FCF | 8.41 |
| Interest Coverage | 2.00 |
Financial Efficiency
Return on equity (ROE) is 6.97% and return on invested capital (ROIC) is 4.13%.
| Return on Equity (ROE) | 6.97% |
| Return on Assets (ROA) | 4.98% |
| Return on Invested Capital (ROIC) | 4.13% |
| Return on Capital Employed (ROCE) | 9.51% |
| Weighted Average Cost of Capital (WACC) | 4.00% |
| Revenue Per Employee | 12.17B |
| Profits Per Employee | 749.07M |
| Employee Count | 3,410 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 6.72 |
Taxes
In the past 12 months, IDX:MEDC has paid 5.03 trillion in taxes.
| Income Tax | 5.03T |
| Effective Tax Rate | 64.21% |
Stock Price Statistics
The stock price has decreased by -2.03% in the last 52 weeks. The beta is 0.30, so IDX:MEDC's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -2.03% |
| 50-Day Moving Average | 1,648.10 |
| 200-Day Moving Average | 1,448.75 |
| Relative Strength Index (RSI) | 27.72 |
| Average Volume (20 Days) | 76,152,975 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:MEDC had revenue of IDR 41.51 trillion and earned 2.55 trillion in profits. Earnings per share was 103.49.
| Revenue | 41.51T |
| Gross Profit | 24.77T |
| Operating Income | 11.05T |
| Pretax Income | 7.83T |
| Net Income | 2.55T |
| EBITDA | 19.88T |
| EBIT | 11.05T |
| Earnings Per Share (EPS) | 103.49 |
Balance Sheet
The company has 9.05 trillion in cash and 63.55 trillion in debt, with a net cash position of -54,499.48 billion or -2,208.19 per share.
| Cash & Cash Equivalents | 9.05T |
| Total Debt | 63.55T |
| Net Cash | -54,499.48B |
| Net Cash Per Share | -2,208.19 |
| Equity (Book Value) | 40.79T |
| Book Value Per Share | 1,508.51 |
| Working Capital | 2.85T |
Cash Flow
In the last 12 months, operating cash flow was 16.42 trillion and capital expenditures -8,863.12 billion, giving a free cash flow of 7.56 trillion.
| Operating Cash Flow | 16.42T |
| Capital Expenditures | -8,863.12B |
| Depreciation & Amortization | 9.29T |
| Net Borrowing | -1,383.25B |
| Free Cash Flow | 7.56T |
| FCF Per Share | 306.20 |
Margins
Gross margin is 59.66%, with operating and profit margins of 26.61% and 6.15%.
| Gross Margin | 59.66% |
| Operating Margin | 26.61% |
| Pretax Margin | 18.86% |
| Profit Margin | 6.15% |
| EBITDA Margin | 47.89% |
| EBIT Margin | 26.61% |
| FCF Margin | 18.20% |
Dividends & Yields
This stock pays an annual dividend of 53.45, which amounts to a dividend yield of 4.44%.
| Dividend Per Share | 53.45 |
| Dividend Yield | 4.44% |
| Dividend Growth (YoY) | 18.58% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 53.17% |
| Buyback Yield | 1.44% |
| Shareholder Yield | 5.88% |
| Earnings Yield | 8.59% |
| FCF Yield | 25.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 11, 2017. It was a forward split with a ratio of 4.
| Last Split Date | Sep 11, 2017 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
IDX:MEDC has an Altman Z-Score of 1.06 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.06 |
| Piotroski F-Score | 4 |